Back
Biogen 10K Form
Sell
40
BIIB
Biogen
Last Price:
$137.09
Seasonality Move:
-2.65%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive BIIB News And Ratings
See the #1 stock for the next 7 days that we like better than BIIB
BIIB Financial Statistics
Sales & Book Value
Annual Sales: | $9.7B |
---|---|
Cash Flow: | $694.6M |
Price / Cash Flow: | 7.93 |
Annual Sales: | $114.71 |
Price / Book: | 1.2 |
Profitability
EPS (TTM): | 11.19000 |
---|---|
Net Income (TTM): | $1.6B |
Gross Margin: | $7.4B |
Return on Equity: | 10.33% |
Return on Assets: | 5.98% |
Biogen Earnings Forecast
Key Biogen Financial Ratios
-
The Gross Profit Margin over the past 41 years for BIIB is 76.12%.
-
The Selling, General & Administrative Expenses for BIIB have been equal to 24.84% of Gross Profit Margin.
-
The Research & Development expenses have been 21.10% of Revenue.
-
The Interest Expense is 15.34% of Operating Income.
-
The Net Earning history of BIIB is 16.87% of Total Revenues.
-
Per Share Earnings over the last 41 years have been positive in 30 years.
Biogen Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | BIIB |
CUSIP: | 09062X |
Website: | biogen.com |
Debt
Debt-to-Equity Ratio: | 0.38 |
---|---|
Current Ratio: | 1.35 |
Quick Ratio: | 0.77 |
Price-to-Earnings
Trailing P/E Ratio: | 12.23 |
---|---|
Forward P/E Ratio: | 8.63 |